₹1,561.90-0.30 (-0.02%)
04:01 PM, 17-Sep-2024₹1,561.70-16.05 (-1.02%)
03:49 PM, 17-Sep-2024BSE : 524816
NSE : NATCOPHARM
Sector : Health care
ISIN Code : INE987B01026
Last Updated: 17-Sep-2024 | 04:01 PM IST
Market Cap (₹ Cr) | 27,974 |
Traded Value (₹ Cr) | 1.75 |
Volume (Shares) | 11,183 |
Face Value (₹) | 2 |
52-Week High (₹) | 1,638.35 |
52-Week High Date | 12-Sep-2024 |
52-Week Low (₹) | 725.00 |
52-Week Low Date | 02-Nov-2023 |
All Time High (₹) | 1,638.35 |
All Time High Date | 12-Sep-2024 |
All Time Low (₹) | 1.60 |
All Time Low Date | 17-Sep-2001 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 27,970 |
EPS - TTM (₹) [C] | 91.37 |
P/E Ratio (X) [C] | 17.09 |
Face Value (₹) | 2 |
Latest Dividend (%) | 150.00 |
Latest Dividend Date | 23-Aug-2024 |
Dividend Yield (%) | 0.60 |
Book Value Share (₹) [C] | 326.79 |
P/B Ratio (₹) [C] | 4.78 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Tata Equity P/E Fund - (G) | 224.17 | 14,58,000 | 2.48 |
Tata Equity P/E Fund-(IDCW-Trigger-Opt B-10%) | 224.17 | 14,58,000 | 2.48 |
Tata Equity P/E Fund - (IDCW-Trigger - Opt A - 5%) | 224.17 | 14,58,000 | 2.48 |
Tata Equity P/E Fund - Direct (G) | 224.17 | 14,58,000 | 2.48 |
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt A-5%) | 224.17 | 14,58,000 | 2.48 |
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt B-10%) | 224.17 | 14,58,000 | 2.48 |
SBI Magnum Midcap Fund (G) | 115.40 | 7,50,551 | 0.54 |
SBI Magnum Midcap Fund (IDCW) | 115.40 | 7,50,551 | 0.54 |
SBI Magnum Midcap Fund - Direct (G) | 115.40 | 7,50,551 | 0.54 |
SBI Magnum Midcap Fund - Direct (IDCW) | 115.40 | 7,50,551 | 0.54 |
Load more
Today's Low/High (₹) | 1,558.15 1,583.10 |
Week Low/High (₹) | 1,535.20 1,639.00 |
Month Low/High (₹) | 1,425.00 1,639.00 |
Year Low/High (₹) | 724.20 1,639.00 |
All time Low/High (₹) | 1.60 1,639.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 1.05% | 1.04% | 1.41 | 1.51% |
1 Month | 6.71% | 6.82% | 3.29 | 3.58% |
3 Month | 29.04% | 29.00% | 7.91 | 8.32% |
6 Month | 63.33% | 63.41% | 14.37 | 15.42% |
1 Year | 76.48% | 77.01% | 22.47 | 25.88% |
3 Year | 65.75% | 66.60% | 40.78 | 44.55% |
Chairman & Managing Director : V C Nannapaneni
Vice Chairman & CEO : Rajeev Nannapaneni
Vice President & Director : PSRK Prasad
President & Director : D Linga Rao
Vice President & Director : Pavan Bhat
Company Sec. & Compli. Officer : Venkat Ramesh
Independent Director : A D Murthy Chavali
Independent Director : B. Lakshminarayana
Independent Director : Kantipudi Suma
Independent Director : Nitin Jain
Independent Director : Vijayabhaskar Dronadula
Registered Office: Natco House, Road No 2 Banjara Hills,Hyderabad,Telangana-500033 Ph: 91-040-23547532
1. What's the Natco Pharma Ltd share price today?
Natco Pharma Ltd share price was Rs 1,561.90 at 04:01 PM IST on 17th Sep 2024. Natco Pharma Ltd share price was down by 0.02% from the previous closing price of Rs 1,562.20. Natco Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Natco Pharma Ltd stock?
The performance of the Natco Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Natco Pharma Ltd?
Natco Pharma Ltd has a market capitalisation of Rs 27,974 crore.
4. What is Natco Pharma Ltd's 52-week high/low share price?
The Natco Pharma Ltd’s 52-week high share price is Rs 1,638.35 and 52-week low share price is Rs 725.00.
5. Is the Natco Pharma Ltd profitable?
On a consolidated basis, Natco Pharma Ltd reported a profit of Rs 636.30 crore on a total income of Rs 1,276.70 crore for the quarter ended 2024. For the year ended Jun 2024, Natco Pharma Ltd had posted a profit of Rs 668.50 crore on a total income of Rs 1,410.70 crore.
6. Which are Natco Pharma Ltd’s peers in the Health care sector?
Natco Pharma Ltd’s top 5 peers in the Health care sector are Suven Pharma, J B Chemicals &, Emcure Pharma, Natco Pharma, Pfizer, Laurus Labs, Alembic Pharma.
7. Who owns how much in Natco Pharma Ltd?
Key changes to the Natco Pharma Ltd shareholding are as follows: